? Deciphera $DCPH has scooped Agios? chief commercial officer Steve Hoerter to fill retiring CEO Michael Taylor?s shoes. The Waltham, MA-based biotech is placing its trust in Hoerter?s sales acumen, especially for cancer drugs, acquired throughout his career at companies like Clovis, Roche, Genentech, Chiron, and Eli Lilly. The first Phase III trial of ripretinib, in gastrointestinal tumors, is due to read out soon.